| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
296,250,000 |
| Market
Cap: |
343.65(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7252 - $1.94 |
|
| Level
I Sector: |
Energy |
| Level
II Sector: |
Energy |
| Level
III Sector: |
Independent Oil & Gas |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 3.7 |
| Insider 6 Months : 3.7 |
| Insider 3/6 Months : 7.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from contraceptive to bio-identical hormone therapy pharmaceutical products for the treatment of vasomotor symptoms and dyspareunia. Co.'s contraceptive product consist of ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) a reversible prescription contraceptive that can prevent pregnancy. Co.'s menopause portfolio includes IMVEXXY (estradiol vaginal inserts) for the treatment of dyspareunia; and BIJUVA (estradiol and progesterone) capsules for the treatment of vasomotor symptoms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
3,118 |
3,118 |
8,412 |
8,412 |
| Total Buy Value |
$2,809 |
$2,809 |
$11,947 |
$11,947 |
| Total People Bought |
2 |
2 |
3 |
3 |
| Total Buy Transactions |
4 |
4 |
6 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
19,050 |
| Total Sell Value |
$0 |
$0 |
$0 |
$43,683 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Thompson Tommy G |
|
• • – |
2025-04-14 |
4 |
B |
$1.00 |
$326 |
D/D |
325 |
14,779 |
0.01 |
9% |
|
| Walker Marlan D |
Chief Executive Officer |
• • – |
2025-04-14 |
4 |
B |
$1.00 |
$489 |
D/D |
490 |
73,639 |
0.01 |
9% |
|
| Walker Marlan D |
Chief Executive Officer |
• • – |
2025-04-10 |
4 |
B |
$0.86 |
$1,000 |
D/D |
1,167 |
73,149 |
0.01 |
28% |
|
| Walker Marlan D |
Chief Executive Officer |
• • – |
2025-04-09 |
4 |
B |
$0.87 |
$994 |
D/D |
1,136 |
71,982 |
0.01 |
26% |
|
| Walker Marlan D |
Chief Executive Officer |
• • – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,281 |
70,846 |
|
- |
|
| Thompson Tommy G |
|
• • – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
14,454 |
|
- |
|
| Collins Cooper C. |
|
• • – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
60,516 |
|
- |
|
| Naughton Gail K |
|
• • – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
8,500 |
|
- |
|
| Collins Cooper C. |
|
• • – |
2024-08-22 |
4 |
B |
$1.73 |
$7,099 |
D/D |
4,094 |
52,016 |
0.01 |
-51% |
|
| Collins Cooper C. |
|
• • – |
2024-08-21 |
4 |
B |
$1.70 |
$2,039 |
D/D |
1,200 |
47,922 |
0.01 |
-39% |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-12-07 |
4 |
S |
$2.24 |
$10,187 |
D/D |
(4,550) |
62,565 |
|
16% |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-12-06 |
4 |
S |
$2.31 |
$33,496 |
D/D |
(14,500) |
67,115 |
|
16% |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,000 |
81,615 |
|
- |
|
| Rosen David Efraim |
10% Owner |
– – • |
2023-11-15 |
4 |
A |
$2.28 |
$1,999,998 |
I/I |
877,192 |
2,946,908 |
|
- |
|
| Ziegler Joseph |
Principal Financial Officer |
• – – |
2023-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
|
- |
|
| Rosen David Efraim |
See Remarks |
– • • |
2023-06-28 |
4 |
A |
$3.68 |
$1,149,998 |
I/I |
312,525 |
2,069,716 |
|
- |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-04-26 |
4/A |
S |
$3.64 |
$2,518 |
D/D |
(692) |
11,615 |
|
- |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-04-26 |
4/A |
OE |
$0.00 |
$0 |
D/D |
2,744 |
12,307 |
|
- |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-04-12 |
4 |
S |
$3.65 |
$4,276 |
D/D |
(1,170) |
12,307 |
|
-5% |
|
| Walker Marlan D |
Chief Executive Officer |
• – – |
2023-04-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,508 |
13,477 |
|
- |
|
| Donegan Michael C |
Prin. Fin. and Acctg. Officer |
• – – |
2023-04-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
61,853 |
|
- |
|
| Donegan Michael C |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-27 |
4 |
S |
$5.09 |
$249 |
D/D |
(49) |
11,853 |
|
26% |
|
| Donegan Michael C |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-26 |
4 |
S |
$5.08 |
$8,371 |
D/D |
(1,648) |
11,902 |
|
12% |
|
| Donegan Michael C |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,940 |
13,550 |
|
- |
|
| Donegan Michael C |
Prin. Fin. and Acctg. Officer |
• – – |
2023-01-24 |
4 |
S |
$5.31 |
$37 |
D/D |
(7) |
7,610 |
|
16% |
|
230 Records found
|
|
Page 1 of 10 |
|
|
0.04 (3.57%) 
